BRIEF published on 06/19/2025 at 17:51, 9 months 6 days ago Présentations scientifiques clés sur l'Imeglimine à l'ADA 2025 Diabète Présentations Scientifiques Sumitomo Pharma Potentiel Thérapeutique Iméglimine
PRESS RELEASE published on 06/19/2025 at 17:46, 9 months 6 days ago Inside Information / Other news releases Poxel presents new Imeglimin data at ADA 2025 diabetes conference, highlighting therapeutic potential. Key presentations by Japanese experts Diabetes Therapeutic Potential Poxel Imeglimin ADA 2025
PRESS RELEASE published on 06/19/2025 at 17:46, 9 months 6 days ago Informations privilégiées / Autres communiqués Des leaders d'opinion présentent le potentiel thérapeutique de l'Imeglimine lors de l'ADA 2025, le plus grand congrès sur le diabète. POXEL SA annonce cinq présentations à Chicago, Illinois Congrès Diabète Poxel SA Iméglimine ADA 2025
BRIEF published on 06/06/2025 at 19:10, 9 months 19 days ago Poxel : Détails sur le capital social et les droits de vote Droits De Vote Capital Social Actions Informations Réglementées Poxel
BRIEF published on 06/06/2025 at 19:10, 9 months 19 days ago Poxel: Details of share capital and voting rights Share Capital Voting Rights Actions Regulated Information Poxel
PRESS RELEASE published on 06/06/2025 at 19:05, 9 months 19 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel communique le nombre d'actions et de droits de vote composant son capital social conformément aux réglementations en vigueur Capital Social Informations Réglementées Biopharmaceutique Maladies Métaboliques Poxel
BRIEF published on 05/28/2025 at 07:35, 9 months 29 days ago TWYMEEG® Data Unveiled at Japan Diabetes Society Meeting Clinical Trials Diabetes Treatment TWYMEEG® Poxel SA Japan Diabetes Society
BRIEF published on 05/28/2025 at 07:35, 9 months 29 days ago Les données TWYMEEG® dévoilées lors de la réunion de la Société japonaise du diabète Essais Cliniques Traitement Du Diabète TWYMEEG® Poxel SA Société Japonaise Du Diabète
PRESS RELEASE published on 05/28/2025 at 07:30, 9 months 29 days ago Inside Information / Other news releases New clinical and scientific data on TWYMEEG® to be presented at the 68th Annual Meeting of the Japan Diabetes Society, showcasing efficacy, safety, and benefits in diverse patient groups Clinical Data Scientific Data TWYMEEG® Sumitomo Pharma Japan Diabetes Society
PRESS RELEASE published on 05/28/2025 at 07:30, 9 months 29 days ago Informations privilégiées / Autres communiqués Présentation à venir de nouvelles données cliniques et scientifiques sur TWYMEEG® lors du 68ème Congrès annuel de la Société Japonaise du Diabète par Poxel SA, société biopharmaceutique au stade clinique Japon Diabète Poxel TWYMEEG Données Cliniques
Published on 03/26/2026 at 04:55, 3 hours 52 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 7 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 17 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 13 hours 32 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 08:20, 27 minutes ago Eurobattery Minerals initiates comprehensive metallurgical testwork with SLR for the San Juan tungsten project
Published on 03/26/2026 at 08:00, 46 minutes ago PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 47 minutes ago Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 47 minutes ago CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 08:00, 47 minutes ago LPKF reports slight improvement in earnings in 2025 and initiates Group realignment
Published on 03/26/2026 at 07:30, 1 hour 17 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 1 hour 17 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 13 hours 53 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 14 hours 16 minutes ago Strong investment performance and active roll-out of our strategy
